Aedes aegypti, commonly known as the yellow fever mosquito, is a highly adapted, invasive mosquito species recognized as a ...

A new study analyzed piRNA — first discovered in 2006 — as a strong predictor of short-term survival in older patients. It ...

European biotech needs specialized capital and stronger continuity across funding stages to get to the next level, writes ...

Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation for oncology and neurological disorders, ...

Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced the ...

Ractigen Therapeutics, a clinical-stage biopharmaceutical company focused on developing next-generation RNA-based medicines, today announce ...

The search for life beyond Earth has traditionally focused on exoplanets orbiting sun-like stars, which is a G-type star.

Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation ...

Researchers at Umeå University have identified two human cell proteins, NUP98 and NUP153, that play a crucial role in how ...

Macquarie University has officially opened a $96 million RNA Research and Manufacturing Facility. Macquarie University has ...

Protein droplets serve important biological functions within cells, but in neurodegenerative diseases like Alzheimer's, these ...

Flares on small stars can expand the boundaries of zones suitable for the emergence of life. A group of researchers from ...